Country: Malta
Language: English
Source: Medicines Authority
HYPROMELLOSE
Macarthys Laboratories Limited Bampton Road, Harold Hill, Romford Essex, RM3 8UG, United Kingdom
S01KA02
HYPROMELLOSE 3 mg/ml
EYE DROPS, SOLUTION
HYPROMELLOSE 3 mg/ml
OTC
OPHTHALMOLOGICALS
Withdrawn
2007-07-09
Page 1 of 3 SUMMARY OF PRODUCT CHARACTERISTICS 1. TRADE NAME OF THE MEDICINAL PRODUCT Hypromellose Eye Drops BPC 0.3% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Hypromellose BP (4500) 3. PHARMACEUTICAL FORM Eye drops, Solution 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS To provide tear-like lubrication for the symptomatic relief of dry eyes and eye irritation associated with deficient tear production. As an ocular lubricant for artificial eyes. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Adults, children and the elderly The dose depends on the need for lubrication. Usually one or two drops to each eye three times daily or as prescribed. 4.3. CONTRA-INDICATIONS Hypersensitivity to any component. Contains benzalkonium chloride, soft contact should not be worn. 4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE If irritation persists or worsens, or headache, eye pain, vision changes or continuous redness occur, discontinue use and consult a physician. Pharmacogenetic problems None known. 4.5. INTERACTIONS WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION None known. Page 2 of 3 4.6. PREGNANCY AND LACTATION There is insufficient evidence of safety in pregnancy and this product should, therefore, only be used in pregnancy if it is considered essential by the physician. 4.7. EFFECTS ON ABILITY TO DRIVE AND USE MACHINES May cause transient mild stinging or temporary blurring of vision. Do not drive or operate machinery unless vision is clear. 4.8. UNDESIRABLE EFFECTS May cause transient mild stinging or temporary blurring of vision. 4.9. OVERDOSE Not applicable. 5. PHARMACOLOGICAL PROPERTIES 5.1. PHARMACODYNAMIC PROPERTIES This product is a sterile, isotonic, buffered solution of Hypromellose. It is used a Read the complete document